Staphylococcus aureus infections are still a concern in the United States, despite a decline seen in hospital-onset MRSA infections since 2005.
No significant differences in surgical complication risk were seen in early or delayed cholecystectomy for acute cholangitis and acute cholecystitis.
A large outbreak of extensively drug-resistant typhoid fever in Pakistan during 2016-2018 resulted in 5 travel-related cases in the United States.
The FDA has granted Breakthrough Therapy designation to CP101 for the treatment of patients with recurrent Clostridium difficile.
Both filings have been granted Priority Review by the Agency.
SHEA guideline reflects the potential for clinically significant cross transmission in the intraoperative environment.
Patients diagnosed with community-acquired pneumonia with higher levels of fibroblast growth factor-21 may have higher mortality rates and longer hospitalizations.
Diagnosing coinfection in pneumonia can be challenging because of timing of the sample collection and false-negative results when the viruses replicate in the lower respiratory tract.